These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 158350)

  • 21. Antihypertensive therapy, serum lipids, coronary heart disease and hypertension--balancing the risks and benefits of treatment.
    Houston MC
    West J Med; 1986 Aug; 145(2):219-21. PubMed ID: 3765601
    [No Abstract]   [Full Text] [Related]  

  • 22. [Prognostic implications of left ventricular hypertrophy in arterial hypertension].
    Kannel WB
    Arch Mal Coeur Vaiss; 1990 Dec; 83 Spec No 4():11-21. PubMed ID: 2150470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retrospective and prospective research on hypertension-related end-organ damage.
    Perloff D
    J Cardiovasc Pharmacol; 1994; 24 Suppl A():S1-5. PubMed ID: 7603071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversal of left ventricular hypertrophy following treatment of hypertension with isradipine.
    Saragoça MA; Portela JE; Abreu P; Plavnik F; Ventura R; Vanneta A; Ajzen H; Ramos OL
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S28-30. PubMed ID: 1720481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Smoking, antihypertensive treatment benefit, and comprehensive antihypertensive treatment approach: some thoughts on the results of the International Prospective Primary Prevention Study in Hypertension.
    Bolli P; Bühler FR; McKenzie JK
    J Cardiovasc Pharmacol; 1990; 16 Suppl 7():S77-80. PubMed ID: 1708033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute blood pressure reduction in the presence of hypertensive cardiac hypertrophy: any interference with coronary circulation?
    Guazzi MD; Alimento M; Guazzi M; Maltagliati A; Pepi M
    Scand J Clin Lab Invest Suppl; 1989; 196():53-61. PubMed ID: 2530622
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of the normalization of arterial pressure on electrocardiographic changes in 97 patients with essential hypertension].
    Pamato AT; Abate M; Barace OM
    Medicina (B Aires); 1982; 42(1):21-6. PubMed ID: 7132698
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effects of indenolol on left ventricular mass in patients with essential arterial hypertension].
    Sau F; Seguro C; Lai C; Orani E; Soro A; Onnis E; Cherchi A
    Cardiologia; 1990 Nov; 35(11):925-30. PubMed ID: 2151570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Is antihypertensive treatment a risk factor of coronary disease? Therapy-related triglyceride increase nor diabetes increase the risk].
    Samuelsson O; Pennert K; Andersson O; Berglund G; Hedner T; Persson B; Wedel H; Wilhelmsen L
    Lakartidningen; 1998 Mar; 95(11):1120-3. PubMed ID: 9542820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypertension and atherosclerosis: therapeutic implications.
    Schoenberger JA
    Prim Care; 1983 Mar; 10(1):29-34. PubMed ID: 6553938
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cardiac structure and function in patients with obstructive sleep apnea syndrome and co-prevalent arterial hypertension. Influence of CPAP therapy].
    Duchna HW; Myslinski W; Dichmann M; Rasche K; Schultze-Werninghaus G; Orth M
    Med Klin (Munich); 2006 Jan; 101(1):1-8. PubMed ID: 16418808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study.
    Wachtell K; Okin PM; Olsen MH; Dahlöf B; Devereux RB; Ibsen H; Kjeldsen SE; Lindholm LH; Nieminen MS; Thygesen K
    Circulation; 2007 Aug; 116(7):700-5. PubMed ID: 17664372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood pressure and the risk of cardiovascular disease.
    MacMahon S
    N Engl J Med; 2000 Jan; 342(1):50-2. PubMed ID: 10620650
    [No Abstract]   [Full Text] [Related]  

  • 34. Antihypertensive therapy--going to the heart of the matter.
    Messerli FH
    Circulation; 1990 Mar; 81(3):1128-35. PubMed ID: 1968365
    [No Abstract]   [Full Text] [Related]  

  • 35. [Electrocardiographic findings in hypertensive heart disease--detection, prevalence, significance, progression and regression].
    Uchida E
    Nihon Rinsho; 1992 Apr; 50 Suppl():564-73. PubMed ID: 1386124
    [No Abstract]   [Full Text] [Related]  

  • 36. Electrocardiographic changes in the course of antihypertensive treatment.
    Freis ED
    Am J Med; 1983 Sep; 75(3A):111-5. PubMed ID: 6226187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of coronary heart disease and left ventricular hypertrophy in the Hypertension Detection and Follow-up Program.
    Borhani NO; Blaufox MD; Oberman A; Polk BF
    Prog Cardiovasc Dis; 1986; 29(3 Suppl 1):55-62. PubMed ID: 2947267
    [No Abstract]   [Full Text] [Related]  

  • 38. [Possible reverse development of myocardial hypertrophy and ischemia in patients with hypertension after short-term antihypertensive therapy].
    Gurgenian SV; Oganesian NM; Mikaelian ES; Grigorian TZ; Nikogosian KG
    Kardiologiia; 1986 Oct; 26(10):94-7. PubMed ID: 2948051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Development of heart hypertrophy in hypertension].
    Gurgenian SV; Adamian KG; Mikaelian ES; Grigorian TZ; Babaian AS
    Kardiologiia; 1983 Apr; 23(4):45-9. PubMed ID: 6223168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect of antihypertensive drugs on cardiac hypertrophy].
    Hayashi D
    Nihon Rinsho; 2000 Feb; 58 Suppl 2():241-4. PubMed ID: 11028332
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.